Stemedica Cell Technologies, Inc. Ischemic Tolerant Stem Cells Produce Significant Improvement in Cardiac Function After Heart Attack
4/3/2012 10:12:22 AM
More...
|
Stemedica Cell Technologies, Inc. Treats First Patient with Ischemic Allogeneic Mesenchymal Stem Cells
3/24/2011 10:44:45 AM
More...
|
Stemedica Cell Technologies, Inc. Receives Approval From University of California, San Diego (UCSD) to Initiate Ischemic Stroke Study With Adult Allogeneic Stem Cells
2/17/2011 6:21:18 AM
More...
|
FDA Approves Stemedica Cell Technologies, Inc. IND for Ischemic Stroke Clinical Trial
4/21/2010 8:36:45 AM
More...
|
Stemedica Cell Technologies, Inc. Files IND Application With FDA for Treatment of Stroke With Adult Allogeneic Mesenchymal Stem Cells
3/19/2010 10:59:34 AM
More...
|
Stemedica Cell Technologies, Inc. Completes Meeting With the FDA
10/15/2009 8:21:00 AM
More...
|
United States Patent and Trademark Office Publishes Stemedica Cell Technologies, Inc.'s Patent Application for the Treatment of Diabetic Retinopathy
9/8/2009 7:59:37 AM
More...
|
The Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica Cell Technologies, Inc.
9/8/2009 7:56:53 AM
More...
|
Stemedica Cell Technologies, Inc. Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
9/2/2009 11:13:45 AM
More...
|
Stemedica Cell Technologies, Inc. Selected by World Stem Cell Summit to Present Scientific Discoveries
8/27/2009 8:25:46 AM
More...
|
|